A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT05465707 · UNKNOWN
Trial details
- NCT number
- NCT05465707
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-30
- Primary completion
- 2023-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.